The Latest Breaking News on Pharma

The Wiltshire-based business specialises in respiratory medicines and inhaler devices

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy

Federal officials say an increasing number of fake prescription pills containing potentially deadly fentanyl are helping drive overdose death rates to record levels in the U.S. And officials warn that some of the pills are being manufactured in rainbow colors designed to look like candy

Recent studies had shown the app had a 92 per cent success rate in diagnosing the virus among symptomatic patients, but more clinical trials were needed for it to gain regulatory approval.

For the first time in a decade, Americans will pay less next year on monthly premiums for Medicare’s Part B plan, which covers routine doctors’ visits and other outpatient care

Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc.

Atai Life Sciences' (NASDAQ: ATAI) wholly-owned subsidiary EmpathBio has received Medsafe central regulatory and the Health and Disability Ethics Committees (HDEC) approvals to begin participant enrollment in its Phase 1 trial of proprietary MDMA-based drug EMP-01

Gainers

Vulnerable groups may have already been called to have their fourth Covid-19 jab

Biopharmaceutical company Bristol Myers Squibb (BMY) reported stable revenue growth for the second quarter thanks to outstanding clinical and operational performance. Furthermore, despite generating significant momentum over the past few months, the stock is trading at a discounted valuation. So, we think it may be prudent to scoop its shares…

Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors in the form of speakers and consulting fees to persuade them to prescribe its multiple sclerosis drugs